Companies / Adicet Bio, Inc. / Activity
Activity — Adicet Bio, Inc.
20 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | RA Capital Management, L.P. 10% owner | Buy | Common Stock | $543.4K | +75K +6.75% | 1,182,624 12.63% of shares | high |
| Feb 19, 2026 | RA Capital Management, L.P. 10% owner | Buy | Common Stock | $535.5K | +74K +7.19% | 1,107,873 11.83% of shares | high |
| Feb 18, 2026 | RA Capital Management, L.P. 10% owner | Buy | Common Stock | $525.0K | +75K +7.78% | 1,033,605 11.04% of shares | high |
| Apr 8, 2026 | Orbimed Advisors LLC 10% owner | Sell | Common Stock | $263.5K | -40K -100.00% | 0 0.00% of shares | medium |
| Apr 8, 2026 | Orbimed Advisors LLC 10% owner | Sell | Common Stock | $204.6K | -33K -100.00% | 0 0.00% of shares | medium |
| Apr 7, 2026 | Orbimed Advisors LLC 10% owner | Sell | Common Stock | $191.5K | -29K -45.64% | 34,923 0.37% of shares | medium |
| Apr 7, 2026 | Orbimed Advisors LLC 10% owner | Sell | Common Stock | $15.3K | -2K -6.87% | 32,523 0.35% of shares | low |
| Jan 24, 2026 | Schor Chen CEO | Other | Common Stock | $14.8K | -2K -20.47% | 6,820 0.07% of shares | low |
| Jan 24, 2026 | Harvey Brian Nicholas Executive | Other | Common Stock | $4.6K | -546 -9.59% | 5,145 0.05% of shares | low |
| Jan 24, 2026 | Aftab Blake Executive | Other | Common Stock | $4.5K | -535 -15.22% | 2,981 0.03% of shares | low |
| Jan 24, 2026 | Healey Don Executive | Other | Common Stock | $4.5K | -535 -13.42% | 3,452 0.04% of shares | low |
| Jun 19, 2026 | Schor Chen CEO | Grant | Stock Option (Right to Buy) | — | +55K | 55,000 0.59% of shares | low |
| Apr 27, 2026 | RA Capital Management, L.P. 10% owner | Other | Pre-Funded Warrant (Right to Buy) | — | +250K +21.69% | 1,402,833 14.99% of shares | low |
| Apr 27, 2026 | RA Capital Management, L.P. 10% owner | Other | Common Stock | — | -250K -21.14% | 932,624 9.96% of shares | low |
| Jun 21, 2026 | Dubin Steve Director | Grant | Stock Option (Right to Buy) | — | +4K | 4,200 0.04% of shares | low |
| Mar 25, 2026 | Maltzman Julia D. Executive | Grant | Stock Option (Right to Buy) | — | +73K | 72,555 0.78% of shares | low |
| Mar 25, 2026 | Aftab Blake Executive | Grant | Stock Option (Right to Buy) | — | +73K | 72,555 0.78% of shares | low |
| Mar 25, 2026 | Healey Don Executive | Grant | Stock Option (Right to Buy) | — | +43K | 43,361 0.46% of shares | low |
| Mar 25, 2026 | Harvey Brian Nicholas Executive | Grant | Stock Option (Right to Buy) | — | +43K | 43,361 0.46% of shares | low |
| Mar 25, 2026 | Schor Chen CEO | Grant | Stock Option (Right to Buy) | — | +469K | 468,555 5.01% of shares | low |